Koninklijke Philips N.V.
PHG Healthcare Medical Devices
Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.
Follow PHG
Koninklijke Philips N.V. (PHG) EV/Sales
As of 16 October 2026, Koninklijke Philips N.V. (PHG) trades at a EV/Sales of 1.4×. Over the past ten years it has ranged from 0.7× (November 2022) to 2.1× (September 2018); the current reading is higher than 51% of that period. That is below the Medical Devices industry median of 2.2× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 1.5× | (0.88%) |
| FY2024 | 1.5× | 32.38% |
| FY2023 | 1.1× | 28.81% |
| FY2022 | 0.9× | (42.08%) |
| FY2021 | 1.5× | (18.71%) |
| FY2020 | 1.9× | 30.64% |
| FY2019 | 1.4× | 16.96% |
| FY2018 | 1.2× | (29.53%) |
| FY2017 | 1.8× | 61.88% |
| FY2016 | 1.1× | 12.96% |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.5× | (0.20%) |
| Mar 2026 | 1.5× | 1.19% |
| Dec 2025 | 1.5× | (10.68%) |
| Sep 2025 | 1.7× | 10.50% |
| 36 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| PHG Koninklijke Philips N.V. | 1.4× |
| SNN Smith & Nephew SNATS, Inc. compare | 1.5× |
| GEHC GE HealthCare Technologies Inc. compare | 1.9× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 3.0× |
| GMED Globus Medical, Inc. compare | 3.4× |
| STE STERIS plc compare | 3.8× |
| DXCM DexCom, Inc. compare | 6.6× |
| EW Edwards Lifesciences Corporation compare | 7.2× |
| PEN Penumbra, Inc. compare | 8.0× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)